The first group, FM1, included individuals with a signature enriched for gene expression of extracellular matrix (ECM) associated with connective tissue disorders and down regulation of Rho GDP Dissociation Inhibitor (RhoGDI) signaling pathway. This evidence concerns the gene ARHGDIA and connective tissue disorder.